InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.41
(
0.53%
)
US TECH 100
19,301.60
(
0.70%
)
Dow Jones
38,672.58
(
0.22%
)
Brent Oil
83.34
(
1.47%
)
Bitcoin
65,819.80
(
-1.23%
)

Replies to post #3497 on Ayala Pharmaceuticals Inc (ADXS)

Replies to #3497 on Ayala Pharmaceuticals Inc (ADXS)

BioInfo

04/20/15 4:02 PM

#3498 RE: DewDiligence #3497

agree on sentiment, but current valuation is warranted, given most companies in late stage phase 3 are between $500M-$1B, this one just started phase1/2 enrollment on MRK deal